Overview
Metastatic transitional cell carcinoma, also known as urothelial carcinoma, refers to bladder cancer that has spread to distant sites. Management involves a multidisciplinary approach and shared decision-making with patients 1.Diagnosis
Thorough diagnosis is emphasized for muscle-invasive and metastatic bladder cancer (MMIBC) 1.Management
Consider susceptible FGFR3 alterations to select patients with unresectable or metastatic urothelial carcinoma for treatment 1.Key Recommendations
Emphasize thorough diagnosis, treatment, and follow-up for patients with MMIBC 1. (Evidence: Expert opinion)
Stress the importance of a multidisciplinary approach to the treatment of MMIBC patients 1. (Evidence: Expert opinion)
Highlight the importance of shared decision-making with patients regarding MMIBC management 1. (Evidence: Expert opinion)References
1 van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Compérat E, Dimitropoulos K et al.. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines. European urology 2025. link